Joakim L.
- Country
- Sweden
- Department
- Infektionskliniken
Research Overview
- Evaluation of Pivmecillinam and Amoxicillin/Clavulanic Acid for Oral Step-Down Therapy in Febrile UTIs Due to ESBL-Producing Enterobacterales
- Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized controlled non-inferiority multicenter trial
Data & Insights
Has run more than one trial at 4 of 27 partner sites.
Specializations
Infectious Disease Management
The investigator specializes in studying urinary tract infections (UTIs), with particular emphasis on cases involving multidrug-resistant bacteria. Their research focuses on developing alternative treatment approaches for complex infections.
- Antimicrobial Resistance
- UTI Treatment Strategies
- Alternative Antibiotic Therapies
A key area of interest includes managing infections caused by ESBL-producing Enterobacterales.
Bacteriology
The investigator concentrates on understanding and treating infections caused by resistant bacterial strains. Their work encompasses the study of bacterial resistance mechanisms and their clinical implications.
- Bacterial Resistance Patterns
- Enterobacterales Infections
- Clinical Microbiology
Special attention is given to developing treatment solutions for complex bacterial infections.
Therapeutic Innovation
The investigator explores novel therapeutic approaches in treating antibiotic-resistant infections. Their research aims to identify effective alternatives to conventional antibiotic treatments.
- Alternative Treatment Regimens
- Oral Antibiotic Therapy
- Treatment Safety Evaluation
Focus areas include developing step-down treatment protocols for severe infections.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.